Wealth Effects LLC Cuts Stock Holdings in Beyond Air, Inc. (NASDAQ:XAIR)

Wealth Effects LLC lowered its stake in Beyond Air, Inc. (NASDAQ:XAIR) by 14.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 196,800 shares of the company’s stock after selling 33,000 shares during the period. Wealth Effects LLC’s holdings in Beyond Air were worth $71,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. bought a new stake in Beyond Air in the 2nd quarter worth $47,000. Baldwin Wealth Partners LLC MA boosted its holdings in shares of Beyond Air by 721.3% during the fourth quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock worth $110,000 after purchasing an additional 270,500 shares during the period. Finally, Soros Fund Management LLC bought a new stake in shares of Beyond Air in the third quarter worth about $573,000. Institutional investors own 31.50% of the company’s stock.

Beyond Air Stock Down 1.8 %

Shares of NASDAQ:XAIR opened at $0.39 on Wednesday. The stock’s 50-day moving average is $0.45 and its 200 day moving average is $0.45. The company has a market cap of $28.37 million, a PE ratio of -0.28 and a beta of -0.17. The company has a debt-to-equity ratio of 0.37, a current ratio of 5.76 and a quick ratio of 5.38. Beyond Air, Inc. has a 1 year low of $0.30 and a 1 year high of $2.17.

Beyond Air (NASDAQ:XAIR) last announced its earnings results on Monday, November 11th. The company reported ($0.28) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.02. Beyond Air had a negative return on equity of 227.29% and a negative net margin of 2,369.17%. The company had revenue of $0.80 million during the quarter, compared to the consensus estimate of $1.19 million. During the same quarter in the prior year, the company earned ($0.51) earnings per share. Sell-side analysts anticipate that Beyond Air, Inc. will post -0.78 EPS for the current year.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.